Canada prioritizes review as US authorizes Pfizer’s COVID Vaccine for children aged 5-11

Canada has prioritized review of CIVID vaccine for younger children as United States authorized Pfizer’s COVID Vaccine for children aged 5-11.

“Health Canada is aware that the U.S. FDA has authorized Comirnaty Pfizer-BioNTech’s Covid Vaccine for children aged 5-11,” Health Canada said in a statement

The statement further added Health Canada’s review is ongoing and is being prioritized.